267 related articles for article (PubMed ID: 14533700)
21. Primary amoebic meningoencephalitis in an infant.
Mittal N; Mahajan L; Hussain Z; Gupta P; Khurana S
Indian J Med Microbiol; 2019; 37(1):120-122. PubMed ID: 31424023
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Naegleria fowleri strains isolated from human cases of primary amoebic meningoencephalitis in Mexico.
Cervantes-Sandoval I; de Serrano-Luna JJ; Tapia-Malagón JL; Pacheco-Yépez J; Silva-Olivares A; Galindo-Gómez S; Tsutsumi V; Shibayama M
Rev Invest Clin; 2007; 59(5):342-7. PubMed ID: 18268889
[TBL] [Abstract][Full Text] [Related]
23. Naegleria meningitis: a rare survival.
Jain R; Prabhakar S; Modi M; Bhatia R; Sehgal R
Neurol India; 2002 Dec; 50(4):470-2. PubMed ID: 12577098
[TBL] [Abstract][Full Text] [Related]
24. CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).
Debnath A; Calvet CM; Jennings G; Zhou W; Aksenov A; Luth MR; Abagyan R; Nes WD; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006104. PubMed ID: 29284029
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of the primary amoebic meningoencephalitis due to Naegleria fowleri.
Hara T; Fukuma T
Parasitol Int; 2005 Dec; 54(4):219-21. PubMed ID: 16002330
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
Smith PF; Booker BM; Ogundele AB; Kelchin P
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606
[TBL] [Abstract][Full Text] [Related]
27. Identification and significance of Naegleria fowleri isolated from the hot spring which related to the first primary amebic meningoencephalitis (PAM) patient in Taiwan.
Tung MC; Hsu BM; Tao CW; Lin WC; Tsai HF; Ji DD; Shen SM; Chen JS; Shih FC; Huang YL
Int J Parasitol; 2013 Aug; 43(9):691-6. PubMed ID: 23665128
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin.
Vargas-Zepeda J; Gómez-Alcalá AV; Vásquez-Morales JA; Licea-Amaya L; De Jonckheere JF; Lares-Villa F
Arch Med Res; 2005; 36(1):83-6. PubMed ID: 15900627
[TBL] [Abstract][Full Text] [Related]
29. In vivo study of artemisinin and its derivatives against primary amebic meningoencephalitis caused by Naegleria fowleri.
Gupta S; Ghosh PK; Dutta GP; Vishwakarma RA
J Parasitol; 1995 Dec; 81(6):1012-3. PubMed ID: 8544041
[TBL] [Abstract][Full Text] [Related]
30. Fatal Primary Amebic Meningoencephalitis due to
Hong KW; Jeong JH; Byun JH; Hong SH; Ju JW; Bae IG
Yonsei Med J; 2023 Oct; 64(10):641-645. PubMed ID: 37727924
[TBL] [Abstract][Full Text] [Related]
31. Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case.
Cope JR; Conrad DA; Cohen N; Cotilla M; DaSilva A; Jackson J; Visvesvara GS
Clin Infect Dis; 2016 Mar; 62(6):774-6. PubMed ID: 26679626
[TBL] [Abstract][Full Text] [Related]
32. The first association of a primary amebic meningoencephalitis death with culturable Naegleria fowleri in tap water from a US treated public drinking water system.
Cope JR; Ratard RC; Hill VR; Sokol T; Causey JJ; Yoder JS; Mirani G; Mull B; Mukerjee KA; Narayanan J; Doucet M; Qvarnstrom Y; Poole CN; Akingbola OA; Ritter JM; Xiong Z; da Silva AJ; Roellig D; Van Dyke RB; Stern H; Xiao L; Beach MJ
Clin Infect Dis; 2015 Apr; 60(8):e36-42. PubMed ID: 25595746
[TBL] [Abstract][Full Text] [Related]
33. Quinupristin-dalfopristin and linezolid: evidence and opinion.
Eliopoulos GM
Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
[TBL] [Abstract][Full Text] [Related]
34. Oleic Acid Coated Silver Nanoparticles Showed Better
Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
[No Abstract] [Full Text] [Related]
35. Phenotypic Screens Reveal Posaconazole as a Rapidly Acting Amebicidal Combination Partner for Treatment of Primary Amoebic Meningoencephalitis.
Colon BL; Rice CA; Guy RK; Kyle DE
J Infect Dis; 2019 Mar; 219(7):1095-1103. PubMed ID: 30358879
[TBL] [Abstract][Full Text] [Related]
36. In vitro effect of antifungal drugs on pathogenic Naegleria spp.
Tiewcharoen S; Junnu V; Chinabut P
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):38-41. PubMed ID: 12118457
[TBL] [Abstract][Full Text] [Related]
37. Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review.
Barnett ND; Kaplan AM; Hopkin RJ; Saubolle MA; Rudinsky MF
Pediatr Neurol; 1996 Oct; 15(3):230-4. PubMed ID: 8916161
[TBL] [Abstract][Full Text] [Related]
38. Risk for transmission of Naegleria fowleri from solid organ transplantation.
Roy SL; Metzger R; Chen JG; Laham FR; Martin M; Kipper SW; Smith LE; Lyon GM; Haffner J; Ross JE; Rye AK; Johnson W; Bodager D; Friedman M; Walsh DJ; Collins C; Inman B; Davis BJ; Robinson T; Paddock C; Zaki SR; Kuehnert M; DaSilva A; Qvarnstrom Y; Sriram R; Visvesvara GS
Am J Transplant; 2014 Jan; 14(1):163-71. PubMed ID: 24279908
[TBL] [Abstract][Full Text] [Related]
39. A case of primary amebic meningoencephalitis caused by Naegleria fowleri in Bangladesh.
Sazzad HMS; Luby SP; Sejvar J; Rahman M; Gurley ES; Hill V; Murphy JL; Roy S; Cope JR; Ali IKM
Parasitol Res; 2020 Jan; 119(1):339-344. PubMed ID: 31734864
[TBL] [Abstract][Full Text] [Related]
40. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
